Plus therapeutics to participate in panel at the canaccord genuity horizons in oncology virtual conference

Austin, texas, april 18, 2023 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (the “company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, announced today that norman lafrance, m.d., chief medical officer and senior vice president, will participate as a panel presenter at the canaccord genuity horizons in oncology virtual conference.
pstv Ratings Summary
pstv Quant Ranking